Revista da Sociedade Brasileira de Medicina Tropical (Jan 2022)

Maternal Mortality in Brazil, 1990 to 2019: a systematic analysis of the Global Burden of Disease Study 2019

  • Lisiane Freitas Leal,
  • Deborah Carvalho Malta,
  • Maria de Fatima Marinho Souza,
  • Ana Maria Nogales Vasconcelos,
  • Renato Azeredo Teixeira,
  • Guilherme Augusto Veloso,
  • Sônia Lansky,
  • Antonio Luiz Pinho Ribeiro,
  • Giovanny Vinícius Araújo de França,
  • Mohsen Naghavi

DOI
https://doi.org/10.1590/0037-8682-0279-2021
Journal volume & issue
Vol. 55, no. suppl 1

Abstract

Read online

Abstract INTRODUCTION Maternal death continues to be one of the most challenging public health problems that needs to be addressed in low and middle-income countries. The objective of this study was to describe the problem of maternal death in Brazil, using estimates from the Global Burden of Disease Study (GBD). METHODS This study used data from the GBD 2019 to show the numbers of deaths and the Maternal Mortality Ratio (MMR) - number of deaths/100,000 live births - in Brazil and its 27 Federated Units (FU), for ages 10 to 54 years, from 1990 to 2019. The annual variation of the MMR was estimated in 1990, 2010, and 2019. The MMR were shown for specific causes as well as for five-year age groups. The estimates were presented with 95% uncertainty intervals (UI). RESULTS The number of maternal deaths, as well as the MMR showed a 49% reduction from 1990 to 2019. This reduction occurred heterogeneously throughout the country, and the profile of the MMR for specific causes changed between 1990 and 2019: from hypertensive gestation diseases, to indirect maternal deaths, followed by hypertensive gestation diseases. In the extreme age groups, the MMR is higher, with mortality increasing exponentially in direct proportion with age. CONCLUSIONS Maternal deaths in Brazil have decreased substantially since 1990; however, the numbers still fall short of what was established by the World Health Organization (WHO). Indirect causes are the greatest problem in more than 60% of the FU, especially for hypertensive pregnancy diseases.

Keywords